Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

AIDS

Volumn 12, Issue 18, 1998, Pages 2447-2457

  Mwinga, A ^a,b   Hosp, M ^a,b   Godfrey Faussett, P ^a,b   Quigley, M ^b   Mwaba, P ^a   Mugala, B N ^a   Nyirenda, O ^a   Luo, N ^a   Pobee, J ^a   Elliott, A M ^a,b   McAdam, K P W J ^b   Porter, J D H ^b  

^a UNIVERSITY TEACHING HOSPITAL   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

AIDS; HIV; Preventive therapy; Tuberculin skin test; Tuberculosis

Indexed keywords

HEMOGLOBIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TUBERCULIN TEST; TUBERCULOSIS; ZAMBIA;

EID: 7844219854     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199818000-00014     Document Type: Article

References (21)

1. Fylkesnes K, Musonda RM, Kasumba K, et al.: The HIV epidemic in Zambia: socio-demographic prevalence patterns and indications of trends among childbearing women. AIDS 1997, 11:339-345.
2. Duncan LE, Elliott AM, Hayes RJ, et al.: Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans R Soc Trop Med Hyg 1995, 89:37-40.
3. O'Brien RJ, Perriens JH: Preventive therapy for tuberculosis in HIV infection: the promise and the reality. AIDS 1995, 9:665-673.
4. Reichman LB: HIV infection - a new face of tuberculosis. Bull Int Union against Tuberc Lung Dis 1988, 63:19-26.
5. 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993, 167:43-48.
6. Goletti D, Weissman D, Jackson RW, et al.: Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996, 157:1271-1278.
7. Ferebee SH: Controlled chemoprophylaxis trial in tuberculosis. A general review. Adv Fuberc Res 1969, 17:28-106.
8. Selwyn PA, Hartel D, Lewis VA, et al.: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus Infection. N Engl J Med 1989, 320:545-550.
9. Guelar A, Gatell JM, Verdejo J, et al.: A prospective study of the risk of tuberculosis among HIV infected patients. AIDS 1993, 7:1345-1349.
10. Pape JW, Simone SS, Ho JL, Hafner A, Johnson Jr WD: Effect of isoniazid prophylaxis on the incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342:268-272.
11. Hawken MP, Meme HK, Elliott LC, et al.: Isoniazid preventive therapy for tuberculosis in HIV-1 infected adults: results of a randomized controlled trial. AIDS 1997, 11:875-882.
12. Whalen C, Johnson JL, Okwera A, et al.: A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997, 337:801-808.
13. Canetti G, Fox W, Khomenko A, et al.: Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in TB control programmes. Bull WHO 1969, 41:21-43.
14. Wadhawan D, Hira S, Mwansa N, Sunkutu R, Adera P, Perine P: Preventive tuberculosis chemotherapy with isoniazid (INH) among patients infected with HIV-1. Ninth International Conference on AIDS in affiliation with the Fourth SID World Congress. Berlin, 6-11 June 1993 [abstract PO-BO7-1114].
15. Lifson AR, Allen S, Wolf W, et al.: Classification of HIV infection and disease in women in Rwanda. Evaluation of the World Health Organisation HIV staging system and recommended modifications. Ann Intern Med 1995, 122:262-270.
16. Post FA, Wood R, Maartens G: CD4 and total lymphocyte counts as predictors of HIV disease progression. Q J Med 1996, 89:505-508.
17. Comstock GW, Baum C, Snider DE: Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis 1984, 119:827-830.
18. Elliott AM, Halwindii B, Hayes R, et al.: The impact of the human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg 1993, 96:1-11.
19. Angell M: The ethics of clinical research in the third world. N Engl J Med 1997, 337:847-849.
20. World Health Organisation: Tuberculosis preventive therapy in HIV-infected individuals. Wkly Epidemiol Rec 1993, 68:361-368.
21. Foster S, Godfrey-Faussett P, Porter J: Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. AIDS 1997, 11:919-925.